Nanomedicine Specialists are at the cutting edge of healthcare, utilizing nanotechnology to develop innovative treatments, diagnostic tools, and preventative measures. By working with particles on the nanometer scale (1-100 nanometers), these experts harness unique properties such as enhanced drug solubility, targeted delivery, and improved bioavailability. Nanomedicine offers the potential to create highly personalized therapies, particularly in the treatment of complex diseases like cancer, neurodegenerative conditions, and infections. Through their work, they aim to minimize side effects and maximize therapeutic effects, making treatments more effective and accessible. They also contribute to improving patient outcomes by tailoring treatments to individual genetic profiles, enhancing precision medicine.
These specialists are heavily involved in the design of advanced drug delivery systems, where nanoparticles are used to deliver medication directly to the targeted site, often reducing the need for invasive procedures and ensuring controlled release over time. Nanomedicine specialists also play a key role in the development of cutting-edge diagnostic techniques, including imaging tools that can detect diseases at the molecular level, which helps in early detection and more precise treatment planning. Collaborating closely with clinical researchers, engineers, and biologists, these experts are transforming theoretical nanotechnology into real-world medical solutions. As nanomedicine continues to evolve, these specialists remain integral to the ongoing advancement of modern healthcare.
Title : Principles and standards for managing healthcare transformation towards personalized, preventive, predictive, participative precision medicine ecosystems
Bernd Blobel, University of Regensburg, Germany
Title : From marker to mechanism: Ligand discovery enables functional analysis of OR51E1, an ectopic olfactory receptor, in prostate cancer
Vladlen Slepak, University of Miami School of Medicine, United States
Title : Hydrogen sulfide in sepsis: From bench to bedside
Madhav Bhatia, University of Otago, New Zealand
Title : Tailored cellular environments to enable drug design
Lan Wang, Paretor LLC, United States
Title : Development of novel drug delivery pathways enabled by perillyl alcohol (NEO100), A monoterpene with multifaceted biomedical applications
Axel H Schonthal, University of Southern California, United States
Title : A NAMs-compatible mechanopharmacological model of drug penetration in the urinary bladder
Kunal Sharma, Swisss Federal Institute of Technology Lausanne, Switzerland
Title : Application of quality by design for pulmonary liposomes: Preliminary study to nano in-microparticle
Lucas Amaral Machado, University of Sao Paulo State – UNESP, Brazil
Title : Integrated Raman, SERS and computational approaches for the study of bioactive molecules in pharmaceutical chemistry
Maria Cristina Gamberini, University of Modena and Reggio Emilia, Italy
Title : The impact of metal-decorated polymeric nanodots on proton relaxivity
Paulo Cesar De Morais, Catholic University of Brasilia, Brazil
Title : Hepatotoxic botanicals-shadows of pearls
Consolato M Sergi, University of Alberta, Canada